fda warning letter compounding semaglutide news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Out of Shortage, Into Controversy:

Thiazolidinediones (TZD) drugs Systematic reviews and meta-analyses have demonstrated that TZD drugs are associated with a reduction in lung cancer risk in patients with type 2 diabetes of approximately 20% [98], and has a preventive effect on prostate cancer [102]

Can I Recover Compensation From a Gastroparesis Lawsuit

Effects of semaglutide and empagliflozin on inflammatory markers in patients with type 2 diabetes

PT-141 was developed as the safer, more targeted alternative

Differential splicing of the phospholipid hydroperoxide glutathione peroxidase gene in diploid and haploid male germ cells in the rat

But if the pigment has settled deeper, or if you have a medium to dark skin tone, complete removal can take several months